Overview
A well-established Pharma Marketing Company, founded in 2016, is seeking strategic investment to fuel its next phase of growth. The company operates from a 1,800 sq. ft. fully furnished and well-equipped office on lease (₹47,000/month) and has built a strong presence in the pharmaceutical sector. With a diversified product portfolio of over 100+ formulations, including tablets, capsules, syrups, nasal sprays, and ear drops, the company has successfully tied up with 8 reputed manufacturers and developed a wide distribution network of 70+ distributors. Currently, the business maintains a stock of around ₹3 crore, with debtors of ₹1.5 crore and creditors of ₹1 crore. It has achieved a healthy turnover of ₹6.23 crore with the support of a strong workforce of 50+ employees. The company is now looking to raise ₹5 crore through 25% equity dilution. The funds will be utilized for expansion into new regions, strengthening working capital, and scaling marketing initiatives. This presents an excellent opportunity for investors to partner with a growing pharma enterprise backed by a proven track record and strong industry relationships.
Business Details
Proposed Deal Structure
N.A
Competition / Market
High
Products & Services
Tablet, Capsule, Syrup, Nezal Spray, Ear Drop other 100+ Formulations
Growth Potential
Very high
Financial Details
How the Acquisition Process Works
- 01Contact SellerContact Seller
- 02Teaser/Information MemorandumTeaser/Information Memorandum
- 03Valuation ReportValuation Report
- 04FinancialsFinancials
- 05Schedule an Advisory MeetingBook Your Consultation